Safety and Efficacy of RAD001 (Everolimus) Administered Upon Relapse During or After Adjuvant Treatment in Post-menopausal Women With Hormone Receptor Positive, HER2/neu Negative Locally Advanced or Metastatic Breast Cancer (CRAD001JGR08 “MELPOMENI” study)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety and Efficacy of RAD001 (Everolimus) Administered Upon Relapse During or After Adjuvant Treatment in Post-menopausal Women With Hormone Receptor Positive, HER2/neu Negative Locally Advanced or Metastatic Breast Cancer (CRAD001JGR08 “MELPOMENI” study)

Published:2022-01-29 Issue:2 Volume:42 Page:1031-1041
ISSN:0250-7005
Container-title:Anticancer Research
language:en
Short-container-title:Anticancer Res

Author:

ALEXOPOULOS ATHANASIOS,KARANIKIOTIS CHARISIOS,ARDAVANIS ALEXANDROS,BOUKOVINAS IOANNIS,MAKRANTONAKIS PARISIOS,PAPADIMITRIOU CHRISTOS,ATHANASIADIS ATHANASIOS,BOUTIS ANASTASIOS,GIASSAS STYLIANOS,KAKOLYRIS STYLIANOS,KOUMAKIS GEORGIOS,PAPAZISIS KONSTANTINOS,PSYRRI ADAMANTIA,ZIRAS NIKOLAOS,BAKA SOFIA,KENTEPOZIDIS NIKOLAOS,MICHALAKI VASILIKI

Publisher

Anticancer Research USA Inc.

Subject

Cancer Research,Oncology,General Medicine

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship Between Daily Dose of Everolimus and Treatment Effect in Patients With Luminal HER2-negative Metastatic Breast Cancer;Anticancer Research;2023-11

2. Cellular and molecular basis of therapeutic approaches to breast cancer;Cellular Signalling;2023-01

3. Everolimus pharmacokinetics and exposure-response relationship in Japanese patients with advanced breast cancer;Frontiers in Pharmacology;2022-09-15

4. Everolimus for Treating Hormone Receptor-positive Metastatic Breast Cancer Previously Treated With Cyclin-dependent Kinase 4/6 Inhibitors;Anticancer Research;2022-07-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP